A Randomized Open-Label Trial of Caspofungin Versus Fluconazole to Prevent Invasive Fungal Infections in Children Undergoing Chemotherapy for Acute Myeloid Leukemia (AML)
This randomized phase III trial studies caspofungin acetate to see how it works compared to
fluconazole in preventing invasive fungal infections in patients with acute myeloid leukemia
who are undergoing chemotherapy. Caspofungin acetate or fluconazole may help prevent fungal
infections caused by chemotherapy. It is not yet known whether fluconazole is more effective
than caspofungin acetate in preventing fungal infections in patients with acute myeloid
leukemia who are undergoing chemotherapy.
View this trial on ClinicalTrials.gov
Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.
These resources are provided in partnership with the
Canadian Cancer Society